George W. Korch

Association of intraspecific wounding with hantaviral infection in wild rats (Rattus norvegicus).

The potential for hantaviral transmission among wild Norway rats by wounding associated with aggressive interactions was evaluated using a prospective sero-epidemiological study coupled with a mark-release-recapture survey. There was a significant association between an animals serological status and the presence of wounds. Longitudinal studies of marked and released animals showed seroconversion between captures was associated with wounding between captures more often (33%) than expected by chance, while unwounded animals seroconverted less often (8%) than expected. Typically, less than a 5% difference was found when comparing the incidence of seroconversion with the predicted rate based on wounding and seroprevalence. Infection was highly associated with the onset of sexual maturity and aggression but decoupled from rat age and the length of environmental exposure. Seroconversions occurred at times most associated with aggressive encounters and least associated with amicable behaviours that could lead to aerosol transmission.

A computer simulation of vaccine prioritization, allocation, and rationing during the 2009 H1N1 influenza pandemic

In the fall 2009, the University of Pittsburgh Models of Infectious Disease Agent Study (MIDAS) team employed an agent-based computer simulation model (ABM) of the greater Washington, DC, metropolitan region to assist the Office of the Assistant Secretary of Public Preparedness and Response, Department of Health and Human Services, to address several key questions regarding vaccine allocation during the 2009 H1N1 influenza pandemic, including comparing a vaccinating children (i.e., highest transmitters)-first policy versus the Advisory Committee on Immunization Practices (ACIP)-recommended vaccinating at-risk individuals-first policy. Our study supported adherence to the ACIP (instead of a children-first policy) prioritization recommendations for the H1N1 influenza vaccine when vaccine is in limited supply and that within the ACIP groups, children should receive highest priority.

Effects of hantaviral infection on survival, growth and fertility in wild rat (Rattus norvegicus) populations of Baltimore, Maryland.

Survival, growth rates, body size and fertility of wild caught Norway rats (Rattus norvegicus), infected and uninfected with a Hantavirus (antigenically related to Seoul virus), were compared. No differences were found in the survival of seronegative versus seropositive rats, as measured by mark–recapture experiments. Growth rates, as measured by weight gain but not by increased body length, were slower in seropositive, sexually mature (>200 g) rats, although no differences in the ultimate body size of infected versus uninfected rats were found. No differences in external measures of sexual maturity, or in embryo counts or testes sizes, were found for infected versus uninfected rats. We conclude that hantaviral infections have little or no impact on demographic processes in Norway rat populations.

Body mass as a measure of body size in small mammals

Etude des relations entre la masse corporelle et la taille chez les petits mammiferes. Les especes etudiees sont Sigmadon huspidus, Microtus pennsylvanicus, M. ochrogaster, Peromyscus leucopus, Rattus norvegicus et Mus musculus

LAND USE ASSOCIATIONS AND CHANGES IN POPULATION INDICES OF URBAN RACCOONS DURING A RABIES EPIZOOTIC

Land use associations and changes in population indices were assessed for an urban population of raccoons (Procyon lotor) in Baltimore, Maryland (USA), from January 1984 to December 1987. Records were examined for 1,458 raccoons trapped alive and removed dead from city streets during, and after, the peak of a rabies epizootic. The distribution of raccoons was associated with single-unit residential areas primarily along the northern and western perimeter of the city. Beginning in March 1985 an ending in May 1987, an epizootic of raccoon rabies spread through Baltimore, ultimately resulting in the identification of 95 rabid raccoons. Within the study interval, annual numbers of trapped raccoons remained stable from 1984 to 1986, before showing a marked decline in 1987. The number of raccoons removed as vehicle mortalities (road-kills) varied little from 1984–1985 but declined in the last 2 yr of study. Numbers of other road-killed species did not decrease concurrently, suggesting a specific decrease in the urban raccoon population. The rabies epizootic, in conjunction with the increased city and private control, appears to have contributed to a decline in the number of raccoons in Baltimore.

Framework for leadership and training of Biosafety Level 4 laboratory workers

One-sentence summary for table of contents: Training should include theoretical consideration of biocontainment principles, practical hands-on training, and mentored on-the-job experience.

Absence of Mycoplasma Contamination in the Anthrax Vaccine

Mycoplasma contamination of the licensed anthrax vaccine administered to military personnel has been suggested as a possible cause of Persian Gulf illness. Vaccine samples tested by nonmilitary laboratories were negative for viable mycoplasma and mycoplasma DNA and did not support its survival. Mycoplasma contamination of anthrax vaccine should not be considered a possible cause of illness.

Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus.

Preclinical development of and research on potential Middle East respiratory syndrome coronavirus (MERS-CoV) medical countermeasures remain preliminary; advancements are needed before most countermeasures are ready to be tested in human clinical trials. Research priorities include standardization of animal models and virus stocks for studying disease pathogenesis and efficacy of medical countermeasures; development of MERS-CoV diagnostics; improved access to nonhuman primates to support preclinical research; studies to better understand and control MERS-CoV disease, including vaccination studies in camels; and development of a standardized clinical trial protocol. Partnering with clinical trial networks in affected countries to evaluate safety and efficacy of investigational therapeutics will strengthen efforts to identify successful medical countermeasures.